Top compounds associated with response to PPP1R35


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.6
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Vorinostat gCSI pan-cancer AAC -0.023 0.7
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.013 0.7
mRNA AT13387 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.015 0.7
mRNA NG-25 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.014 0.7
Download CSV